Gold, Deborah T <br/><br/>
Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?  [electronic resource] 

 -  Current osteoporosis reports  Mar 2007 
 - 3-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1544-1873 
<br/><br/><label>Standard No.: </label>10.1007/BF02938616  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Back Pain--etiology<br/>Estrogens--adverse effects<br/>Fatigue--etiology<br/>Female<br/>Fractures, Spontaneous--prevention & control<br/>Hip Fractures--prevention & control<br/>Humans<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--complications<br/>Postmenopause--drug effects<br/>Prevalence<br/>Quality of Life--psychology<br/>Raloxifene Hydrochloride--adverse effects<br/>Risk Factors<br/>Selective Estrogen Receptor Modulators--adverse effects<br/>Spinal Fractures--prevention & control<br/>Tamoxifen--adverse effects<br/>United States--epidemiology